Cymevene 500mg Injection 1's
About Cymevene 500mg Injection 1's
Cymevene 500mg Injection 1's belongs to the class of 'antivirals' used in the treatment of cytomegalovirus (CMV) retinitis. Cytomegalovirus (CMV) retinitis is an infection that affects the retina of the eye caused by a virus called Cytomegalovirus (CMV), especially in AIDS patients. It is a serious infection that can lead to blindness. Cymevene 500mg Injection 1's is also used to prevent Cytomegalovirus disease in transplant patients who are at risk for CMV infection.
Cymevene 500mg Injection 1's contains Ganciclovir, which works by killing and stopping the growth of the cytomegalovirus. Thus, helps to treat Cytomegalovirus (CMV) retinitis.
Cymevene 500mg Injection 1's is a parenteral preparation. It will be administered by a healthcare professional; hence do not self-administer. Common side effects of Cymevene 500mg Injection 1's may include nausea, vomiting, loss of appetite, itching, sensitivity to light (photosensitivity), swelling, redness and tenderness at the injection site. These side effects may not occur in every patient using this medication and gradually resolve over time. If the side effects persist longer or worsen, please inform your doctor.
Let your doctor know if you are allergic to any medications. Inform your doctor if you have a weakened immune system, breathing problems, an electrolyte imbalance, blood disorders, and liver or kidney diseases before starting Cymevene 500mg Injection 1's. Cymevene 500mg Injection 1's is not recommended for use in pregnant and breastfeeding women. Hence, inform your doctor before starting Cymevene 500mg Injection 1's. Avoid alcohol consumption while on treatment with Cymevene 500mg Injection 1's to enable your body to fight off infections. Cymevene 500mg Injection 1's should be avoided in children as the safety and efficacy are not explained.
Uses of Cymevene 500mg Injection 1's
Medicinal Benefits
Cymevene 500mg Injection 1's treats viral infection of the eye caused by Cytomegalovirus (CMV) retinitis. It is also used to treat Cytomegalovirus disease in transplant patients. Cymevene 500mg Injection 1's consists of Gancyclovir, an antiviral drug that works by killing and stopping the growth of the herpes simplex virus on the cornea.
Directions for Use
Storage
Side Effects of Cymevene 500mg Injection 1's
Drug Warnings
Inform your doctor if you are allergic to Cymevene 500mg Injection 1's or any of the components in Cymevene 500mg Injection 1's. It is advised to inform your doctor that you are pregnant or planning a pregnancy as Cymevene 500mg Injection 1's may cause infertility problems and fetal toxicity. Patients with kidney disease should avoid receiving a name and should notify their doctor. Before beginning treatment with Cymevene 500mg Injection 1's, inform your doctor if you have a history of cancer disease. Nursing mothers should avoid breastfeeding while receiving Cymevene 500mg Injection 1's as it passes in breastmilk and cause side effects to infants.
Drug Interactions
Drug-Drug Interactions: Cymevene 500mg Injection 1's may interact with Didanosine, Zidovudine, Probenecid, Imipenem, Cyclosporine or Amphotericin B.
Drug-Food Interactions: No drug-food interactions were found.
Drug-Disease Interactions: Cymevene 500mg Injection 1's may have interactions with liver disease, kidney dysfunction, blood disorders, cancer patients, pregnant women and nursing mothers.
Drug-Drug Interactions Checker List
Habit Forming
Diet & Lifestyle Advise
Special Advise
Disease/Condition Glossary
Cytomegalovirus (CMV) retinitis: This is an eye infection caused when Cytomegalovirus (CMV) affects the retina (light-sensing nerve layer) of the eye, which can lead to blindness. It mainly occurs in weak immune patients, such as AIDS (Acquired immune deficiency syndrome). Symptoms include eye pain, tearing, redness, blurred vision, blind spots and visual disturbances.
Cytomegalovirus disease: It mainly occurs in people with weak immune systems. Cymevene 500mg Injection 1's is used in the treatment of cytomegalovirus (CMV) disease in transplant patients.